One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: Clinico-pathological findings

International Journal of Legal Medicine

Volumn 114, Issue 6, 2001, Pages 352-356

  De Letter, E A ^a   Coopman, Vera A E ^b   Cordonnier, Jan A C M ^b   Piette, M H A ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Toxicological Laboratory Chemiphar NV   (Belgium)

Author keywords

4 Methylthioamphetamine; 4 MTA; Amphetamines; Drug abuse; Intoxication

Indexed keywords

4 METHYLTHIOAMPHETAMINE; AMPHETAMINE DERIVATIVE; DESIGNER DRUG; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DRUG ABUSE; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; INTOXICATION; MALE; MEDICOLEGAL ASPECT; PATHOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AMPHETAMINES; DESIGNER DRUGS; FATAL OUTCOME; FEMALE; HUMANS; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; POISONING; SEROTONIN UPTAKE INHIBITORS;

EID: 0034940176     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004140100204     Document Type: Article

References (31)

1. Fatal poisoning with a new phenylethylamine: 4-Methylthioamphetamine (4-MTA)
2. p-Methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent
3. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methyl-amino) butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAI) and p-methylthioamphetamine (MTA)
4. Deaths associated with MBDB misuse
5. The pathology of the ring-substituted amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
6. Induction of apoptotic cell death in rat thymus and spleen after a bolus injection of methamphetamine
7. Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes
8. Ecstasy-induced toxicity in rat liver
9. Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug
10. Amphetamine derivative fatalities in South Australia - Is "ecstasy" the culprit?
11. Recent paramethoxyamphetamine deaths
12. An initial review of analytical findings in cases involving 4-methylthioamphetamine (4-MTA)
13. Para-methylthioamphetamine, a new amphetamine designer drug of abuse
14. Standardized HPLC/DAD system, based on retention indices and spectral library, applicable for systematic toxicological screening
15. Human deaths and toxic reactions attributed to MDMA and MDEA
16. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives
17. "Ecstasy" and sudden cardiac death
18. Tissue distribution of methylenedioxymethamphetamine
19. Pathology of deaths associated with "ecstasy" and "eve" misuse
20. Contaminants in illicit amphetamine preparations
21. Weakly basic impurities in illicit amphetamine
22. Identification of 3,4-methylenedioxyamphetamine analogs encountered in clandestine tablets
23. Application of solid-phase microextraction to the profiling of an illicit drug: Manufacturing impurities in illicit 4-methoxyamphetamine
24. Analysis of "ecstasy" by capillary electrophoresis
25. Synthesis of 4-methyl-5-arylpyrimidines and 4-arylpyrimidines: Route specific markers for the Leuckardt preparation of amphetamine, 4-methoxyamphetamine, and 4-methylthioamphetamine
26. Recreational use of MDMA
27. Subjective reports of the effects of 3,4-methylenedioxy-methamphetamine in a clinical setting
28. Fatal poisoning by MDMA (ecstasy) and MDEA: A case report
29. Unexpected death in young epileptics